Canlyniadau Chwilio - Nachbur, Ueli

NOD Signaling and Cell Death gan Heim, Valentin J., Stafford, Che A., Nachbur, Ueli

Cael y testun llawn Cael y testun llawn Cael y testun llawn

XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures gan Ellwanger, Kornelia, Briese, Selina, Arnold, Christine, Kienes, Ioannis, Heim, Valentin, Nachbur, Ueli, Kufer, Thomas A

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation gan Lim, Eu Jin, Chin, Ruth, Nachbur, Ueli, Silke, John, Jia, Zhiyuan, Angus, Peter W., Torresi, Joseph

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity gan Heim, Valentin J, Dagley, Laura F, Stafford, Che A, Hansen, Fynn M, Clayer, Elise, Bankovacki, Aleksandra, Webb, Andrew I, Lucet, Isabelle S, Silke, John, Nachbur, Ueli

Cael y testun llawn Cael y testun llawn Cael y testun llawn

XIAP acts as a switch between type I and type II FAS-induced apoptosis signalling gan Jost, Philipp J., Grabow, Stephanie, Gray, Daniel, McKenzie, Mark D., Nachbur, Ueli, Huang, David C.S., Bouillet, Philippe, Thomas, Helen E., Borner, Christoph, Silke, John, Strasser, Andreas, Kaufmann, Thomas

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Eliminating hepatitis B by antagonizing cellular inhibitors of apoptosis gan Ebert, Gregor, Allison, Cody, Preston, Simon, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Silke, John, Begley, C. Glenn, Pellegrini, Marc

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Oligomerization‐driven MLKL ubiquitylation antagonizes necroptosis gan Liu, Zikou, Dagley, Laura F, Shield‐Artin, Kristy, Young, Samuel N, Bankovacki, Aleksandra, Wang, Xiangyi, Tang, Michelle, Howitt, Jason, Stafford, Che A, Nachbur, Ueli, Fitzgibbon, Cheree, Garnish, Sarah E, Webb, Andrew I, Komander, David, Murphy, James M, Hildebrand, Joanne M, Silke, John

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus gan Ebert, Gregor, Preston, Simon, Allison, Cody, Cooney, James, Toe, Jesse G., Stutz, Michael D., Ojaimi, Samar, Scott, Hamish W., Baschuk, Nikola, Nachbur, Ueli, Torresi, Joseph, Chin, Ruth, Colledge, Danielle, Li, Xin, Warner, Nadia, Revill, Peter, Bowden, Scott, Silke, John, Begley, C. Glenn, Pellegrini, Marc

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 gan Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction: TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 gan Etemadi, Nima, Chopin, Michael, Anderton, Holly, Tanzer, Maria C, Rickard, James A, Abeysekera, Waruni, Hall, Cathrine, Spall, Sukhdeep K, Wang, Bing, Xiong, Yuquan, Hla, Timothy, Pitson, Stuart M, Bonder, Claudine S, Wong, Wendy Wei-Lynn, Ernst, Matthias, Smyth, Gordon K, Vaux, David L, Nutt, Stephen L, Nachbur, Ueli, Silke, John

Cael y testun llawn Cael y testun llawn Cael y testun llawn

TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice gan Rickard, James A, Anderton, Holly, Etemadi, Nima, Nachbur, Ueli, Darding, Maurice, Peltzer, Nieves, Lalaoui, Najoua, Lawlor, Kate E, Vanyai, Hannah, Hall, Cathrine, Bankovacki, Aleks, Gangoda, Lahiru, Wong, Wendy Wei-Lynn, Corbin, Jason, Huang, Chunzi, Mocarski, Edward S, Murphy, James M, Alexander, Warren S, Voss, Anne K, Vaux, David L, Kaiser, William J, Walczak, Henning, Silke, John

Cael y testun llawn Cael y testun llawn Cael y testun llawn

A type III effector antagonises death receptor signalling during bacterial gut infection gan Pearson, Jaclyn S, Giogha, Cristina, Ong, Sze Ying, Kennedy, Catherine L, Kelly, Michelle, Robinson, Keith S, Wong, Tania, Mansell, Ashley, Riedmaier, Patrice, Oates, Clare VL, Zaid, Ali, Mühlen, Sabrina, Crepin, Valerie F, Marches, Olivier, Ang, Ching-Seng, Williamson, Nicholas A, O’Reilly, Lorraine A, Bankovacki, Aleksandra, Nachbur, Ueli, Infusini, Giuseppe, Webb, Andrew I, Silke, John, Strasser, Andreas, Frankel, Gad, Hartland, Elizabeth L

Cael y testun llawn Cael y testun llawn Cael y testun llawn

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation gan Pearson, Jaclyn S., Giogha, Cristina, Mühlen, Sabrina, Nachbur, Ueli, Pham, Chi L. L., Zhang, Ying, Hildebrand, Joanne M., Oates, Clare V., Lung, Tania Wong Fok, Ingle, Danielle, Dagley, Laura F., Bankovacki, Aleksandra, Petrie, Emma J., Schroeder, Gunnar N., Crepin, Valerie F., Frankel, Gad, Masters, Seth L., Vince, James, Murphy, James M., Sunde, Margaret, Webb, Andrew I., Silke, John, Hartland, Elizabeth L.

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors gan Calleja, Dale J., Kuchel, Nathan, Lu, Bernadine G. C., Birkinshaw, Richard W., Klemm, Theresa, Doerflinger, Marcel, Cooney, James P., Mackiewicz, Liana, Au, Amanda E., Yap, Yu Q., Blackmore, Timothy R, Katneni, Kasiram, Crighton, Elly, Newman, Janet, Jarman, Kate E., Call, Melissa J., Lechtenberg, Bernhard C., Czabotar, Peter E., Pellegrini, Marc, Charman, Susan A., Lowes, Kym N., Mitchell, Jeffrey P., Nachbur, Ueli, Lessene, Guillaume, Komander, David

Cael y testun llawn Cael y testun llawn Cael y testun llawn